Reuters logo
5 个月前
BRIEF-Cardiome Pharma Corp says Q4 loss per share $0.18
2017年3月7日 / 晚上9点53分 / 5 个月前

BRIEF-Cardiome Pharma Corp says Q4 loss per share $0.18

March 7 (Reuters) - Cardiome Pharma Corp

* Reports FY 2016 revenue $25.3 million

* Cardiome reports fourth quarter and full year 2016 financial results

* Q4 revenue $7.0 million versus I/B/E/S view $6.3 million

* Q4 loss per share $0.18

* Reports FY 2016 revenue up 21 percent

* Q4 earnings per share view $-0.16 -- Thomson Reuters I/B/E/S

* Believe Xydalba sales in 2017, followed by Trevyent launch in 2018/19 will be start of strong revenue growth for years to come Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below